Vital Signs

This week's collection of news and events from the School of Medicine

UNC-Guest Wireless to be discontinued on November 29

ITS plans to permanently remove the wireless access channel known as UNC-Guest from the UNC campus network on Wednesday, November 29. It is being replaced by a more robust and more secure access channel labeled as UNC-Guest-PSK. Read more for information on how to connect to UNC-Guest-PSK.

UNC-Guest Wireless to be discontinued on November 29 - Read More…

Researchers use a skin patch, infrared light, and melanin to battle melanoma

Researchers use a skin patch, infrared light, and melanin to battle melanoma

In lab experiments led by Zhen Gu, PhD, UNC and NC State scientists were able to trigger naturally occurring melanin to boost an immune response against skin cancer cells in mice.

Researchers use a skin patch, infrared light, and melanin to battle melanoma - Read More…

A New Test to Measure the Effectiveness of CF Drugs

A New Test to Measure the Effectiveness of CF Drugs

A new lab model developed by UNC’s Carla Ribeiro, PhD, and colleagues can be used to test new therapeutics for cystic fibrosis.

A New Test to Measure the Effectiveness of CF Drugs - Read More…

Can asthma be controlled with a vitamin supplement?

Can asthma be controlled with a vitamin supplement?

UNC School of Medicine researchers led by Michelle Hernandez, MD, found that asthma patients taking a kind of vitamin E called gamma tocopherol had less inflammation of the airways. The study points to a new way to control asthma’s chronic symptoms.

Can asthma be controlled with a vitamin supplement? - Read More…

How to Reverse Protein Clumping, a hallmark of ALS

How to Reverse Protein Clumping, a hallmark of ALS

Watch this UNC School of Medicine Science Short featuring Todd Cohen, PhD, and his lab's work on the underpinnings of two debilitating diseases.

How to Reverse Protein Clumping, a hallmark of ALS - Read More…

Could this Protein Protect People against Coronary Artery Disease?

Could this Protein Protect People against Coronary Artery Disease?

Research led by UNC’s Jonathan Schisler, PhD, showed much lower levels of the protein CXCL5 in older people with clogged arteries.

Could this Protein Protect People against Coronary Artery Disease? - Read More…

Buse leads clinical trial of new diabetes treatment

Buse leads clinical trial of new diabetes treatment

The study is designed to evaluate whether TTP399 is well tolerated when administered as an add-on to insulin therapy and can improve daily glucose profiles and HbA1c in people living with type 1 diabetes.

Buse leads clinical trial of new diabetes treatment - Read More…

Muñoz receives Fuller Award

Muñoz receives Fuller Award

Cristina Muñoz, MD, associate professor of Obstetrics and Gynecology, has been honored with this year’s H. Fleming Fuller Award. Muñoz received the award on Nov. 13 at a meeting of the UNC Health Care Board of Directors.

Muñoz receives Fuller Award - Read More…

Fat Cell Gene Deficiency Promotes Obesity

Fat Cell Gene Deficiency Promotes Obesity

UNC School of Medicine’s Damaris Lorenzo, PhD, and colleagues show how a gene variant can trigger obesity in mice – without them eating more than control mice – and lead to health concerns related to weight gain.

Fat Cell Gene Deficiency Promotes Obesity - Read More…

New study aims to reduce opioid use while managing chronic pain

New study aims to reduce opioid use while managing chronic pain

A principal investigator of the study is UNC’s Dr. Paul Chelminski, a professor at the UNC School of Medicine with extensive experience studying best practices of prescribing and managing long-term opioid use.

New study aims to reduce opioid use while managing chronic pain - Read More…